Researchers map cancer marker to guide future treatments
NCT ID NCT06925113
Summary
This study aims to understand how common a specific protein marker called HER2 is in recurrent advanced endometrial, ovarian, and cervical cancers in Taiwan. Researchers will look back at the medical records and tissue samples of about 509 patients to see how many have high levels of this marker. The goal is to gather information that could help identify patients who might benefit from existing targeted therapies in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, 833, Taiwan
-
Mackay Memorial Hospital
Taipei, 104, Taiwan
-
National Taiwan University Hospital
Taipei, 100, Taiwan
-
Taichung Veterans General Hospital
Taichung, 407, Taiwan
-
Taipei Veterans General Hospital
Taipei, 112, Taiwan
Conditions
Explore the condition pages connected to this study.